FDA Approval Summary: Pertuzumab, Trastuzumab, and Hyaluronidase–zzxf Injection for Subcutaneous Use in Patients with HER2-positive Breast Cancer
Jennifer J. Gao,Christy L. Osgood,Yutao Gong,Hui Zhang,Erik W. Bloomquist,Xiling Jiang,Junshan Qiu,Jingyu Yu,Pengfei Song,Nam Atiqur Rahman,Haw-Jyh Chiu,Tiffany K. Ricks,Fatima Rizvi,Sherry Hou, Willie Wilson,Abde M. Abukhdeir,Jeffrey Seidman,Soma Ghosh,Reena Philip,William F. Pierce,Vishal Bhatnagar,Paul G. Kluetz,Richard Pazdur,Julia A. Beaver,Laleh Amiri-Kordestani Clinical Cancer Research（2020）
AI 理解论文
溯源树
样例
